Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
S1P1
1 other identifier
observational
80
1 country
1
Brief Summary
Patients seen at the SLUCare Center for Endometriosis (including those with or without pain) undergoing laser excision surgery for known or suspected endometriosis will be recruited for the study. Per the PI's standard surgical approach to endometriosis, all areas of abnormal peritoneum will be excised (removed). After surgical excision has been performed, in order to provide standardized specimens for our research, a 3mm punch biopsy will be obtained from the excised peritoneum tissue. The 3 mm biopsy will be sent for research analysis, and the rest of the excised peritoneum tissue will be sent to histology (SSM) for evaluation and classification as having endometriosis or not. For each patient in the study, blood will also be collected to look for markers for endometriosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 4, 2016
CompletedFirst Posted
Study publicly available on registry
November 25, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2020
CompletedSeptember 10, 2020
September 1, 2020
4 years
October 4, 2016
September 9, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
S1PR1 levels in PBLs with and without endometriosis.
To determine if S1PR1 levels in PBLs can discriminate between patients with endometriosis and patients without endometriosis.
At Surgery
Eligibility Criteria
Patients seen at the Center for Endometriosis (including those with or without pain) undergoing laser excision surgery for known or suspected endometriosis will be recruited for the study.
You may qualify if:
- Patients seen at the Center for Endometriosis (including those with or without pain) who are undergoing excision surgery.
- Patients who are undergoing laser excision surgery for known or suspected endometriosis will be recruited for the study.
- Completed a preoperative questionnaire
You may not qualify if:
- prior bilateral salpingo-oophorectomy
- post natural menopause
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SSM St. Mary's
St Louis, Missouri, 63117, United States
Biospecimen
Per the PI's standard surgical approach to endometriosis, all areas of abnormal peritoneum will be excised (removed). After surgical excision has been performed, in order to provide standardized specimens for our research, a 3mm punch biopsy will be obtained from the excised peritoneum tissue. The 3 mm biopsy will be sent for research analysis, and the rest of the excised peritoneum tissue will be sent to histology (SSM) for evaluation and classification as having endometriosis or not. For each patient in the study, blood will also be collected to look for markers for endometriosis.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
October 4, 2016
First Posted
November 25, 2016
Study Start
September 1, 2016
Primary Completion
September 10, 2020
Study Completion
September 10, 2020
Last Updated
September 10, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share